publication venue for
- High frequency of premature termination mutations in the factor V gene: three factor V deficiency case reports and a mutation review. 2005
- Trousseau-like venous thromboemboli with benign ovarian tumors. 2004
- Acquired von Willebrand syndrome: data from an international registry. 2000
- SARS-CoV-2 Vaccination: Long-Term Follow-Up of Pre-existing and De Novo Immune Thrombocytopenia.. 123. 2022
- Pharmacomechanical Catheter-Directed Thrombolysis in Acute Femoral-Popliteal Deep Vein Thrombosis: Analysis from a Stratified Randomized Trial.. 119. 2019
- Factor VIII, Protein C and Cardiovascular Disease Risk: The REasons for Geographic and Racial Differences in Stroke Study (REGARDS).. 118. 2018
- Identification of unique venous thromboembolism-susceptibility variants in African-Americans.. 117. 2017
- D-dimer and the Risk of Stroke and Coronary Heart Disease. The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.. 117. 2016
- Circulating protein Z concentration, PROZ variants, and unexplained cerebral infarction in young and middle-aged adults.. 117. 2016
- Abnormal megakaryopoiesis and platelet function in cyclooxygenase-2-deficient mice.. 114. 2015
- Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer.. 113. 2014
- Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways.. 110. 2013
- Dysfunction of annexin A2 contributes to hyperglycaemia-induced loss of human endothelial cell surface fibrinolytic activity.. 109. 2013
- Haemostatic safety of a unique recombinant plasmin molecule lacking kringles 2-5.. 104. 2010
- Human solCD39 inhibits injury-induced development of neointimal hyperplasia.. 103. 2009
- Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.. 100. 2008
- Potential role of activated platelets in homing of human endothelial progenitor cells to subendothelial matrix.. 96. 2006
- ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura.. 95. 2006
- Anti-thrombotic effect of bivalirudin compared with eptifibatide and unfractionated heparin in diabetic patients: an ex vivo human study.. 95. 2006
- IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of life.. 91. 2004
- Trophic effects of platelets on cultured endothelial cells are mediated by platelet-associated fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF).. 88. 2002
- Cholesterol-induced thrombogenicity of the vessel wall: inhibitory effect of fluvastatin.. 87. 2002
- Effect of cardiolipin oxidation on solid-phase immunoassay for antiphospholipid antibodies.. 86. 2001
- Human atheromatous plaque extracts induce tissue factor activity (TFa) in monocytes and also express constitutive TFa.. 81. 1999
- Regulation of monocyte tissue factor activity by allogeneic and xenogeneic endothelial cells.. 79. 1998
- Fibrillin containing elastic microfibrils support platelet adhesion under dynamic shear conditions.. 79. 1998
- Acadesine reduces the frequency of coronary artery reocclusion following rt-PA induced thrombolysis in the dog.. 74. 1995
- Relationships between haemostatic factors and capillary morphology in human diabetic neuropathy.. 68. 1992
- Different effects of aspirin, dipyridamole and UD-CG 115 on platelet activation in a model of vascular injury: studies with extracellular matrix covered with endothelial cells.. 56. 1986
- Plasma and platelet fibrinogen differ in gamma chain content.. 51. 1984
- Prevention of intravascular thrombus formation on plastic catheters with heparin-benzalkonium complex: in vivo and in vitro studies.. 41. 1979
- Role of immunologic arterial injury in atherogenesis.. 39. 1978
- The platelet-endothelial cell--VIII axis.. 35. 1976
- Another interaction of the FcR system with IVIG. 2002
- Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and Methodology. 2019
- A possible solution to the paradox of the "lupus anticoagulant": antiphospholipid antibodies accelerate thrombin generation by inhibiting annexin-V. 1999
- Frequency of antibodies directed against heparin-platelet factor 4 in patients exposed to heparin through chronic hemodialysis. 1996
- Outcome studies of pulmonary embolism versus accuracy: they do not equate.. 96. 2006
- Optimizing initial therapy of acute venous thromboembolism.. 90. 2003
- Clinical Decision Rules for Pulmonary Embolism in Hospitalized Patients: A Systematic Literature Review and Meta-analysis. 2017
- The role of thrombin and protease-activated receptors in pain mechanisms. 2010
- Ubiquitylation within signaling pathways in- and outside of inflammation. 2007
- Role of c-kit/Kit ligand signaling in regulating vasculogenesis. 2003
- Antibody-mediated disruption of the annexin-V antithrombotic shield: a new mechanism for thrombosis in the antiphospholipid syndrome. 1999
- Pregnancy loss in the antiphospholipid syndrome. 1999
- The significance of subendothelial von Willebrand factor. 1997
- Cellular receptors in the regulation of plasmin generation. 1995
- Fetal neonatal thrombocytopenia. 1995
- Thrombosis and inflammation as multicellular processes: significance of cell-cell interactions. 1995
- Recommendations for the evaluation and treatment of neonatal autoimmune and alloimmune thrombocytopenia. The Working Party on Neonatal Immune Thrombocytopenia of the Neonatal Hemostasis Subcommittee of the Scientific and Standardization Committee of the ISTH. 1991